Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

7.71
-0.7700-9.08%
Pre-market: 7.67-0.0443-0.57%05:10 EDT
Volume:2.81M
Turnover:22.44M
Market Cap:1.41B
PE:-75.59
High:8.61
Open:8.43
Low:7.64
Close:8.48
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:2.17
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-144.41
PE(LYR):2,404.12

Loading ...

Xeris Names John Shannon as Chair of the Board

Reuters
·
Jul 06

Why Xeris Biopharma (XERS) Is Up 7.7% After Governance, IP, And Balance Sheet Moves - And What's Next

Simply Wall St.
·
Jul 05

Xeris Biopharma Director Nerissa Kreher Files Initial Beneficial Ownership Statement

Reuters
·
Jul 03

Xeris Biopharma Chief Legal Officer Beth Hecht Sells 16,666 Shares Worth $133,865.06

Reuters
·
Jul 03

Xeris Biopharma Grants 221,323 Inducement Rsus to 47 New Employees

Reuters
·
Jul 03

Xeris Taps CEO to Additionally Serve as Chairman

Dow Jones
·
Jun 30

Palvella Therapeutics Appoints Savara CEO Matt Pauls to Board of Directors

Reuters
·
Jun 30

Xeris Names CEO John Shannon Board Chair, Effective July 1, 2026

Reuters
·
Jun 30

Xeris Announces Updates to Its Board of Directors

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Marla Persky to Transition to Lead Independent Director

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Appoints John Shannon as Chair of the Board

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Gets Notice of Allowance From US Patent and Trademark Office for New KEVEYIS Patent

MT Newswires Live
·
Jun 12

Xeris Biopharma gets USPTO notice of allowance for Keveyis patent extending protection to 2039

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Omnicell (OMCL), Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Jun 11

Xeris Biopharma announces private exchange of convertible notes

TIPRANKS
·
Jun 11

BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes

Reuters
·
Jun 11

Xeris Biopharma retires USD 23 million of 8% convertible notes in cash-and-stock exchange

Reuters
·
Jun 11

Xeris Biopharma Announces Private Exchange of Convertible Notes

THOMSON REUTERS
·
Jun 11

Xeris Biopharma - to Retire $23 Mln Principal of Notes for $23 Mln Cash and Shares

THOMSON REUTERS
·
Jun 11

Savara COO Robert Lutz to take CFO role as Lowrance steps down for health reasons

Reuters
·
Jun 09